SCHEMBL4560917

SCHEMBL4560917

CCN(C(=O)C(C)(C)Cc1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
GLA P06280 2/20 0.56
TSHR P16473 1/20 0.56
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
RIPK1 Q13546 2/20 0.46
HPGD P15428 2/20 0.46
TP53 P04637 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HTT P42858 2/20 0.42
MLYCD O95822 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PAX8 Q06710 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17333657 0.81 MEN1 (0.76) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL29184151 0.80 ALDH1A1 (0.63) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL11379 0.78 ALDH1A1 (0.61) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL31211562 0.76 ALDH1A1 (0.63) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL11529 0.75 ALDH1A1 (0.58) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL6020589 0.75 RIPK1 (0.44) ALDH1A1TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL9614332 0.73 ALDH1A1 (0.59) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL27787154 0.73 ALDH1A1 (0.54) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL380050 0.73 ALDH1A1 (0.76) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL1185690 0.73 ALDH1A1 (0.76) ALDH1A1GLATSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181943-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC11, HDAC3 ALDH1A1 532/4885GLA 219/4885TSHR 3972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.